Stuttgart - Delayed Quote EUR

InMed Pharmaceuticals Inc (MWG0.SG)

Compare
0.2980 +0.0340 (+12.88%)
At close: October 25 at 9:35 PM GMT+2
Currency in USD All numbers in thousands
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
4,597.7300
4,597.7300
4,135.5610
1,089.4350
--
--
Cost of Revenue
3,496.8170
3,496.8170
2,732.5250
545.8890
--
--
Gross Profit
1,100.9130
1,100.9130
1,403.0360
543.5460
--
--
Operating Expense
9,235.3430
9,235.3430
9,781.8230
14,335.3020
9,938.2830
--
Operating Income
-8,134.4300
-8,134.4300
-8,378.7870
-13,791.7560
-9,938.2830
--
Net Non Operating Interest Income Expense
527.9010
527.9010
492.4400
96.0900
-344.3330
--
Other Income Expense
-61.9210
-61.9210
-48.1750
-4,904.4510
79.5270
--
Pretax Income
-7,668.4500
-7,668.4500
-7,934.5220
-18,600.1170
-10,203.0890
--
Tax Provision
7.1000
7.1000
13.1000
--
--
--
Net Income Common Stockholders
-7,675.5500
-7,675.5500
-7,947.6220
-18,600.1170
-10,203.0890
--
Diluted NI Available to Com Stockholders
-7,675.5500
-7,675.5500
-7,947.6220
-18,600.1170
-10,203.0890
--
Basic EPS
-0.54
-1.01
-3.25
-33.17
-37.96
--
Diluted EPS
-0.54
-1.01
-3.25
-33.17
-37.96
--
Basic Average Shares
6,052.6990
7,621.0750
2,448.4580
560.8290
268.7930
--
Diluted Average Shares
6,052.6990
7,621.0750
2,448.4580
560.8290
268.7930
--
Rent Expense Supplemental
77.7200
--
--
--
--
69.6237
Total Expenses
12,732.1600
12,732.1600
12,514.3480
14,881.1910
9,938.2830
--
Net Income from Continuing & Discontinued Operation
-7,675.5500
-7,675.5500
-7,947.6220
-18,600.1170
-10,203.0890
--
Normalized Income
-7,622.9172
-7,622.9172
-7,918.7170
-13,695.6660
-10,282.6160
--
Interest Income
527.9010
527.9010
492.4400
96.0900
16.0170
--
Interest Expense
--
--
--
--
360.3500
--
Net Interest Income
527.9010
527.9010
492.4400
96.0900
-344.3330
--
EBIT
-8,134.4300
-8,134.4300
-8,378.7870
-13,791.7560
-9,842.7390
--
EBITDA
-7,529.9120
-7,529.9120
-7,782.7900
-13,279.9690
-9,614.0450
--
Reconciled Cost of Revenue
3,111.8990
3,111.8990
2,338.7770
219.7590
--
--
Reconciled Depreciation
604.5180
604.5180
595.9970
511.7870
228.6940
--
Net Income from Continuing Operation Net Minority Interest
-7,675.5500
-7,675.5500
-7,947.6220
-18,600.1170
-10,203.0890
--
Total Unusual Items Excluding Goodwill
-61.9210
-61.9210
-48.1750
-4,904.4510
79.5270
--
Total Unusual Items
-61.9210
-61.9210
-48.1750
-4,904.4510
79.5270
--
Normalized EBITDA
-7,467.9910
-7,467.9910
-7,734.6150
-8,375.5180
-9,693.5720
--
Tax Rate for Calcs
0.0002
0.0002
0.0004
--
--
--
Tax Effect of Unusual Items
-9.2882
-9.2882
-19.2700
--
--
--
6/30/2020 - 8/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers